论文部分内容阅读
我科自1988年以来,对30例原发性高血压或伴有并发症者给予舌下含服巯甲丙脯酸治疗,现将观察结果报告如下。全部病例均经过询问病史和体格检查,排除继发性高血压.30例中,男15例,女15例.年龄50～73岁(平均62.5±7.6岁),高血压病史7月～30年(平均14±7年)。其中高血压病Ⅱ期9例(30%),Ⅲ期9例(30%),高血压脑病3例(10%),脑溢血4例(13.3%),高血压性心脏病并心衰5例(16.6%),血压平均26.18±3.46/14.98±2.17kPa.
Our department since 1988, 30 cases of essential hypertension or complications associated with sublingual administration of captopril treatment, the observations are reported below. All cases were asked history and physical examination, excluding secondary hypertension.30 cases, 15 males and 15 females.Age of 50 to 73 years (mean 62.5 ± 7.6 years), history of hypertension in July to 30 years (14 ± 7 years on average). There were 9 cases (30%) of stage Ⅱ hypertensive disease, 9 cases (30%) of stage Ⅲ, 3 cases (10%) of hypertensive encephalopathy, 4 cases of stroke (13.3%), 5 cases of hypertensive heart disease and heart failure (16.6%), blood pressure average 26.18 ± 3.46 / 14.98 ± 2.17kPa.